Regulations.gov document
Biosimilarity and Interchangeability: Additional Draft Q&As on Biosimilar Development and…
Notice · FDA-2011-D-0611 · posted Nov 20, 2020
Key facts
| Document ID | FDA-2011-D-0611-0081 |
|---|---|
| Title | Biosimilarity and Interchangeability: Additional Draft Q&As on Biosimilar Development and the Biologics Price Competition and Innovation Act of 2009; Draft Guidance for Industry; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2011-D-0611 |
| Posted | Nov 20, 2020 |
| Federal Register citation | 85 FR 74345 |
| FR document number | 2020-25606 |
| Comment period opens | Nov 20, 2020 |
| Comments due | Jan 20, 2021 |
| Effective date | Nov 20, 2020 |
At a glance
- 1–9 Pages
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: